Tandem lc-ms identification of antitubercular compounds in zones of growth inhibition produced by South African filamentous actinobacteria
dc.contributor.author | Watson, Daniel J. | |
dc.contributor.author | Wiesner, Lubbe | |
dc.contributor.author | Beukes, Denzil | |
dc.date.accessioned | 2023-06-27T08:40:37Z | |
dc.date.available | 2023-06-27T08:40:37Z | |
dc.date.issued | 2023 | |
dc.description.abstract | Novel antitubercular compounds are urgently needed to combat drug-resistant Mycobacterium tuberculosis (Mtb). Filamentous actinobacteria have historically been an excellent source of antitubercular drugs. Despite this, drug discovery from these microorganisms has fallen out of favour due to the continual rediscovery of known compounds. To increase the chance of discovering novel antibiotics, biodiverse and rare strains should be prioritised. Subsequently, active samples need to be dereplicated as early as possible to focus efforts on truly novel compounds. In this study, 42 South African filamentous actinobacteria were screened for antimycobacterial activity using the agar overlay method against the Mtb indicator Mycolicibacterium aurum under six different nutrient growth conditions. Known compounds were subsequently identified through extraction and high-resolution mass spectrometric analysis of the zones of growth inhibition produced by active strains. This allowed the dereplication of 15 hits from six strains that were found to be producing puromycin, actinomycin D and valinomycin. | en_US |
dc.identifier.citation | Watson, D. J. et al. (2023). Tandem lc-ms identification of antitubercular compounds in zones of growth inhibition produced by South African filamentous actinobacteria. Molecules, 28(11), 4276. https://doi.org/10.3390/molecules28114276 | en_US |
dc.identifier.issn | 1420-3049 | |
dc.identifier.uri | https://doi.org/10.3390/molecules28114276 | |
dc.identifier.uri | http://hdl.handle.net/10566/9163 | |
dc.language.iso | en | en_US |
dc.publisher | MDPI | en_US |
dc.subject | Antitubercular | en_US |
dc.subject | Pharmaceuticals | en_US |
dc.subject | Mycobacterium tuberculosis | en_US |
dc.subject | South Africa | en_US |
dc.subject | Covid-19 | en_US |
dc.subject | Public health | en_US |
dc.title | Tandem lc-ms identification of antitubercular compounds in zones of growth inhibition produced by South African filamentous actinobacteria | en_US |
dc.type | Article | en_US |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- watson_tandem lc-ms identification of antitubercular_2023.pdf
- Size:
- 1.86 MB
- Format:
- Adobe Portable Document Format
- Description:
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: